Entity Common Stock, Shares Outstanding of VITASPRING BIOMEDICAL CO. LTD. from 30 Apr 2017 to 06 Jan 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
VITASPRING BIOMEDICAL CO. LTD. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 30 Apr 2017 to 06 Jan 2026.
  • VITASPRING BIOMEDICAL CO. LTD. Entity Common Stock, Shares Outstanding for the quarter ending 06 Jan 2026 was 207,030,030.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

VITASPRING BIOMEDICAL CO. LTD. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 207,030,030 06 Jan 2026 10-Q 13 Jan 2026 2024 Q1
Q4 2025 207,030,030 26 Nov 2025 10-K 01 Dec 2025 2023 FY
Q3 2022 206,520,030 0 0% 31 Oct 2022 10-Q 21 Dec 2022 2023 Q3
Q2 2022 206,520,030 0 0% 31 Jul 2022 10-Q 15 Sep 2022 2023 Q2
Q1 2022 206,520,030 +8,135,015 +4.1% 30 Apr 2022 10-Q 15 Jun 2022 2023 Q1
Q4 2021 206,520,030 -3,150,000 -1.5% 31 Jan 2022 10-K 03 May 2022 2021 FY
Q3 2021 206,520,030 +152,010,000 +279% 31 Oct 2021 10-Q 23 Dec 2021 2022 Q3
Q2 2021 206,520,030 +152,010,000 +279% 31 Jul 2021 10-Q 15 Sep 2021 2021 Q2
Q1 2021 198,385,015 +187,483,009 +1720% 30 Apr 2021 10-Q 14 Jun 2021 2022 Q1
Q4 2020 209,670,030 +198,768,024 +1823% 31 Jan 2021 10-K 14 Apr 2021 2021 FY
Q3 2020 54,510,030 +43,608,024 +400% 31 Oct 2020 10-Q 15 Dec 2020 2021 Q3
Q2 2020 54,510,030 +43,608,024 +400% 31 Jul 2020 10-Q 28 Sep 2020 2021 Q2
Q1 2020 10,902,006 0 0% 30 Apr 2020 10-Q 19 Jun 2020 2021 Q1
Q4 2019 10,902,006 0 0% 31 Jan 2020 10-K 09 Jun 2020 2020 FY
Q3 2019 10,902,006 +7,458,504 +217% 31 Oct 2019 10-Q 12 Dec 2019 2020 Q3
Q2 2019 10,902,006 +7,803,839 +252% 31 Jul 2019 10-Q 27 Aug 2019 2020 Q2
Q1 2019 10,902,006 +7,863,839 +259% 30 Apr 2019 10-Q 03 Jun 2019 2020 Q1
Q4 2018 10,902,006 +7,902,006 +263% 31 Jan 2019 10-K 26 Apr 2019 2019 FY
Q3 2018 3,443,502 31 Oct 2018 10-Q 21 Nov 2018 2019 Q4
Q2 2018 3,098,167 +98,167 +3.3% 31 Jul 2018 10-Q 15 Aug 2018 2019 Q2
Q1 2018 3,038,167 -71,961,833 -96% 30 Apr 2018 10-Q 04 Jun 2018 2019 Q1
Q4 2017 3,000,000 31 Jan 2018 10-K 16 May 2018 2018 FY
Q2 2017 3,000,000 31 Jul 2017 10-Q 15 Nov 2017 2018 Q3
Q1 2017 75,000,000 30 Apr 2017 10-Q 08 Jun 2017 2017 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.